Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Myelogenous Leukemia in Relapse”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00004239
What this trial is testing

506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
Alliance for Clinical Trials in Oncology 10
Large-scale testing (Phase 3)Study completedNCT03182244
What this trial is testing

ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase 3 (FLT3) Mutation

Who this might be right for
AML With FLT3 Mutation
Astellas Pharma Inc 276
Early research (Phase 1)Study completedNCT02732184
What this trial is testing

A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With AML or MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Immedica Pharma AB 21
Early research (Phase 1)Looking for participantsNCT06613217
What this trial is testing

Study of Oral PCLX-001 in R/R Acute Myeloid Leukemia

Who this might be right for
Relapsed Adult AML
Pacylex Pharmaceuticals 35
Early research (Phase 1)Not Yet RecruitingNCT05662904
What this trial is testing

Genetic Ablation of CD33 in HSC to Broaden the Therapeutic Index of CD33-directed Immunotherapy in Patients with AML

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia (AML)
German Cancer Research Center 12
Testing effectiveness (Phase 2)Study completedNCT00078858
What this trial is testing

Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+132 more
Fred Hutchinson Cancer Center 37
Early research (Phase 1)Active Not RecruitingNCT06768476
What this trial is testing

CART123 + Ruxolitinib in Relapsed/Refractory AML

Who this might be right for
Relapsed AMLRefractory AML
University of Pennsylvania 12
Testing effectiveness (Phase 2)Study completedNCT00002833
What this trial is testing

Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes
M.D. Anderson Cancer Center 53
Early research (Phase 1)Study completedNCT04901416
What this trial is testing

Safety and Efficacy of Allogeneic NK Cell Infusions in Patients With Relapsed/Refractory AML and High Risk MDS

Who this might be right for
AML, Adult RecurrentMDS
Coeptis Therapeutics 8
Large-scale testing (Phase 3)Study completedNCT02039726
What this trial is testing

(QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive

Who this might be right for
AML
Daiichi Sankyo 367
Early research (Phase 1)Study completedNCT00401739
What this trial is testing

Safety, Tolerability and Pharmacokinetics of CSL360 in the Treatment of Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
CSL Limited 40
Early research (Phase 1)Looking for participantsNCT06146257
What this trial is testing

GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
GluBio Therapeutics Inc. 48
Testing effectiveness (Phase 2)Study completedNCT02265731
What this trial is testing

Study Evaluating Venetoclax in Subjects With Hematological Malignancies

Who this might be right for
Non-Hodgkin Lymphoma (NHL)Multiple Myeloma (MM)Chronic Lymphocytic Leukemia (CLL)+2 more
AbbVie 38
Testing effectiveness (Phase 2)Study completedNCT02193958
What this trial is testing

Study of FF-10501-01 in Patients With Relapsed or Refractory Hematological Malignancies

Who this might be right for
AMLCMMLMDS
Fujifilm Pharmaceuticals U.S.A., Inc. 55
Testing effectiveness (Phase 2)UnknownNCT04749355
What this trial is testing

Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS

Who this might be right for
AML, AdultMDSRelapse/Recurrence+1 more
BioSight Ltd. 40
Testing effectiveness (Phase 2)UnknownNCT00003758
What this trial is testing

Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia

Who this might be right for
Leukemia
European Organisation for Research and Treatment of Cancer - EORTC 60
Early research (Phase 1)Active Not RecruitingNCT03190278
What this trial is testing

Study Evaluating Safety and Efficacy of UCART123v1.2 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia
Cellectis S.A. 29
Testing effectiveness (Phase 2)Study completedNCT00003396
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Maryland, Baltimore 42
Early research (Phase 1)Not Yet RecruitingNCT07737769
What this trial is testing

Arsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
University of Michigan Rogel Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00512083
What this trial is testing

Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia

Who this might be right for
Leukemia, Myeloid
Antisoma Research 70
Next Page